CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans

Journal of Cutaneous Pathology

Volumn 30, Issue 3, 2003, Pages 185-189

  Calikoglu, Emel ^a   Augsburger, Eric ^b   Chavaz, Pierre ^b   Saurat, Jean Hilaire ^b   Kaya, Gürkan ^b  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; BIOCHEMICAL MARKER; BLOOD CLOTTING FACTOR 13A; CD34 ANTIGEN; CELL SURFACE RECEPTOR; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; ISOPROTEIN; MEMBRANE PROTEIN; PROTEIN ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EXON; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA SPLICING; SKIN BIOPSY; STROMA; TISSUE SECTION; TUMOR CELL;

ANTIGENS, CD44; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; HYALURONIC ACID; IMMUNOENZYME TECHNIQUES; PROTEIN ISOFORMS; SKIN NEOPLASMS;

EID: 0037360718     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2003.300304.x     Document Type: Article

References (33)

1. Vilanova JR, Flint A. The morphologic variations of fibrous histiocytomas. J Cutan Pathol 1974;1: 155.
2. Abenoza P, Lilemoe T. CD34 and Factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 1993;15: 429.
3. Barr RJ, Young Em Jr, King DF. Non-polarizable collagen in dermatofibrosarcoma protuberans: a useful diagnostic aid. J Cutan Pathol 1986;13: 339.
4. Kamino H, Jacobson M. Dermatofibroma extending in to the subcutaneous tissue: Differential diagnosis from dermatofibrosarcoma protuberans. Am J Surg Pathol 1990;14:1156.
5. Cerio R, Spaull J, Wilson Jones E. Histiocytoma cutis: a tumour of dermal dendrocytes (dermal dendrocytoma). Br J Dermatol 1989;120: 197.
6. Ramani P, Bradley NJ, Fletcher CDM. QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathology 1990;17: 237.
7. Cohen PR, Rapini RP, Farhood A. The expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors. J Cutan Pathol 1991;18: 363.
8. Aiba S, Tabata N, Ishii H, Ootani H, Tagami H. Dermatofibrosarcoma protuberans is a unique histiocytic tumor expressing CD34. Br J Dermatol 1992;127: 79.
9. Cohen PR, Rapini RP, Farhood A. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors. J Cutan Pathol 1993;20: 15.
10. Altman DA, Nickoloff BJ, Fivenson DP. Dermatofibrosarcoma strongly express CD34. J Cutan Pathol 1992;19: 509.
11. Altman DA, Nickoloff BJ, Fivenson DP. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol 1993;20: 154.
12. Fitzgibbon JF, Henner MS, Swanson PE, Wich MR. CD34 staining of cutaneous fibrohistiocytic tumors. Specificity and sensitivity as a tumor marker for dermatofibrosarcoma protuberans. J Cutan Pathol 1992; 19: 522.
13. Kamino H, Burchette J, Garcia JA. Immunostaining for CD34 in plaque and nodular areas of dermatofibrosarcoma protuberans. J Cutan Pathol 1992;19: 530.
14. Kutzner H. Expression of the human hematopoietic progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin fixed, paraffin embedded tissue. J Am Acad Dermatol 1993;28: 613.
15. Weiss SW, Nickoloff BJ. CD34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 1993;17: 1039.
16. Nemes Z, Thomazy V. Factor XIIIa and the classic histiocytic markers in malignant fibrous histiocytoma: a comparative immunohistochemical study. Hum Pathol 1988;19: 822.
17. Cohen PR, Rapini RP, Farhood AI. Dermatofibroma and dermatofibrosarcoma protuberans. differential expression of CD34 and Factor XIIIa. Am J Dermatopathol 1994;16: 573.
18. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991;10: 343.
19. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci 1992;89: 121604.
20. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61: 1303.
21. Culty M, Miyake K, Kincade PW, et al. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 1990;111: 2765.
22. Kaya G, Rodrigez I, Jorcano JL, Vassali P, Stamenkovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 1997;11: 996.
23. Kaya G, Augsburger E, Stamenkovic I, Saurat JH. Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus. J Invest Dermatol 2000;115: 1054.
24. Ripellino JA, Klinger MM, Margolis RU, Margolis RK. The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue sections. Application to chick embryo and rat brain. J Histochem Cytochem 1985;33: 1060.
25. Tammi R, Ripellino JA, Margolis RU, Tammi M. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J Invest Dermatol 1988;90: 412.
26. Smith K, Menon P, Rolfe A, et al. Pretreatment with intralesional hyalurinidase prior to excision of dermatofibrosarcoma protuberans. Cancer Lett 1998;131: 117.
27. Underhill CB. CD44: The hyaluronan receptor. J Cell Sci 1992;116: 1055.
28. Underhill CB. Hyaluronan is inversely corralated with the expression of CD44 in the dermal condensation of the embryonic hair follicle. J Invest Dermatol 1993;101: 820.
29. Calikoglu E, Augsburger E, Masouyé I, Chavaz P, Saurat JH, Kaya G. Hyaluronate accumulation and decreased CD44 expression in perifollicular solitary cutaneous myxoma. Dermatology 2002;205: 122.
30. Seiter S, Wolfgang T, Herrmann K, et al. Expression of CD44 splice variants in human skin and epidermal tumors. Wirchows Arch 1996;428: 141.
31. Seiter S, Schadendorf D, Herrmann K, et al. Expression of CD44 variant isoforms in malignant melanoma. Clin Cancer Res 1996;2: 447.
32. Kahara N, Ozaki T, Doi T, et al. CD44 expression in soft tissue sarcomas. Virchows Arch 2000;436: 574.
33. ZöllerM. CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. J Mol Med 1995;73: 425.